Page 69 - OHKF_Biotech_EN
P. 69
Figure 20 Recognised countries under the secondary review approach
Sweden
Finland
Estonia Latvia
Denmark
Netherlands Lithuania
UK Poland
Canada Ireland Czech Republic
Slovakia
Belgium Austria
Luxembourg
USA Hungary
Germany Romania Japan
France Bulgaria
Cyprus
Greece Drug Of ce,
Portugal Department of Health of
Slovenia the Hong Kong SAR Government
Spain
Recognised countries
under the secondary Switzerland Malta
review approach: Italy Australia
32
Source: Drug Office, Department of Health of Hong Kong
67
